Jan Gerstoft

Jan Gerstoft

Professor emeritus, Professor, emeritus

Member of:

  • Internal medicine: infection medicine


  1. Published

    Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation

    Haugaard, A. K., Lund, T. T., Birch, C., Rönsholt, F., Trøseid, M., Ullum, H., Gerstoft, Jan, Jo­hans­son, Pär In­ge­mar , Nielsen, S. D. & Ostrowski, Sisse Rye, 2013, In: AIDS. 27, 17, p. 2749-2758 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Does Contrast Enhancement Predict Survival in Progressive Multifocal Leukoencephalopathy? Reply

    Engsig, F. N., Hansen, A. B. E., Omland, L. H., Kronborg, Gitte, Gerstoft, Jan, Laursen, A. L., Pedersen, C., Mogensen, C. B., Nielsen, L. & Obel, Niels, 2009, In: Journal of Infectious Diseases. 199, 9, p. 1411-1412 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection

    Ronit, A., Salem, M., Hartling, Hans Jakob Stilling, Gaardbo, J. C., Ullum, H., Gerstoft, Jan & Nielsen, S. D., 2013, In: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 121, 5, p. 437-446 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Earlier testing for HIV--how do we prevent late presentation?

    Yazdanpanah, Y., Lange, J., Gerstoft, Jan & Cairns, G., 1 Jan 2010, In: Antiviral Therapy. 15 Suppl 1, p. 17-24 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients

    Legarth, R., Omland, L. H., Kronborg, Gitte, Larsen, C. S., Pedersen, C., Gerstoft, Jan & Obel, Niels, 28 Jan 2014, In: AIDS (London, England). 28, 3, p. 387–396 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Effectiveness of Antiretroviral Therapy in Individuals Who for Economic Reasons Were Switched From a Once-Daily Single-Tablet Regimen to a Triple-Tablet Regimen

    Engsig, F. N., Gerstoft, Jan, Helleberg, M., Nielsen, L. N., Kronborg, Gitte, Mathiesen, L. R. & Obel, Niels, 1 Aug 2014, In: Journal of acquired immune deficiency syndromes (1999). 66, 4, p. 407-413 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trial

    Aladdin, H., Ullum, H., Schjerling, Peter, Skov Jensen, M., Dam Nielsen, S., Mathiesen, L., Gerstoft, Jan, Skinhøj, P. & Klarlund Pedersen, B., Aug 2000, In: Scandinavian Journal of Immunology. 52, 2, p. 212-6 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patients

    Aladdin, H., Larsen, C. S., Schjerling, Peter, Møller, B. K., Buhl, M. R., Gerstoft, Jan, Pedersen, Bente Klarlund & Ullum, H., Mar 2001, In: Scandinavian Journal of Immunology. 53, 3, p. 315-9 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients

    Aladdin, H., Larsen, C. S., Møller, B. K., Ullum, H., Buhl, M. R., Gerstoft, Jan, Skinhøj, P. & Pedersen, Bente Klarlund, Feb 2000, In: Scandinavian Journal of Immunology. 51, 2, p. 168-75 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

    Sulkowski, M., Hezode, C., Gerstoft, J., Vierling, J. M., Mallolas, J., Pol, S., Kugelmas, M., Murillo, A., Weis, N., Nahass, R., Shibolet, O., Serfaty, L., Bourliere, M., DeJesus, E., Zuckerman, E., Dutko, F., Shaughnessy, M., Hwang, P., Howe, A. Y. M., Wahl, J. & 3 others, Robertson, M., Barr, E. & Haber, B., Mar 2015, In: Lancet. 385, 9973, p. 1087-1097 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...34 Next

ID: 986166